Novacyt S.A. (EPA:ALNOV)
France · Delayed Price · Currency is EUR 0.4500
-0.0220 (-4.66%)
Oct 2, 2026, 5:35 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €34.22 million as of October 2, 2026. Its market cap has increased by 1.52% in one year.
Market Cap
34.22M
Enterprise Value
35.76M
Revenue
25.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.45
ChartMarket Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 34.22M, an increase of 45.28%. That is a compound annual growth rate of 2.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 34.22M | 24.12% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 340.06M |
| Eurobio Scientific Société anonyme | 252.71M |
| Median Technologies | 143.12M |
| Guerbet | 84.65M |
| Theraclion | 49.71M |
| Mauna Kea Technologies | 27.00M |
| Diagnostic Medical Systems | 23.48M |
| Implanet | 23.33M |